Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Page 23 Page 24 Page 25 Page 26 Page 27 Page 28 Page 29 Page 30 Page 31 Page 3214 AdvaMed’s Global Strategy and Analysis department works to level the playing field for medical technology companies across borders by advocating for trade, regulatory and reimbursement practices that are fair, transparent and predictable worldwide. Our team of international policy experts works with U.S. and foreign health care and government officials, and organizations like the World Health Organization, the Asia-Pacific Economic Cooperation forum, and other international medical technology associations, to help ensure policies that facilitate worldwide patient access to life-changing innovations. During the year, AdvaMed advocacy helped secure World Trade Organization expansion of the 1996 Information Technology Agreement, thus eliminating burdensome tariffs on $10 billion worth of U.S. medical technology exports. The team marked additional successes and progress points across the globe: CHINA – Two CEO delegations in 2015 – led by AdvaMed Chairman Vince Forlenza of BD and International Board Com- mittee Chairman Kevin Lobo of Stryker – focused on increasing alignment with global regulatory, tendering and reimbursement practices, including practices impacting clinical trials, approval times and unique device identification. In November, successful AdvaMed advocacy helped secure commitments from China at the high-level Joint Commission on Commerce and Trade to treat imported and domestic medical technology the same, expand clinical trial exemption catalogues, enhance the China FDA’s pre-submission consultation process, develop new rules more transparently, and provide annual regulatory approval performance reports. AdvaMed also developed a China code of ethics on appropriate industry interactions with health care providers and related implementation tools. LATIN AMERICA – In October, AdvaMed participated in a delegation of business leaders pursuing reform and investment opportunities in the region, including high-level meetings in Bogota with Colombian President Juan Manuel Santos. In Brazil, AdvaMed partnered with the other three associations in ABIIS to stave off price control efforts, pro- mote the value of medical technology and evaluate regulatory and health technology assessment gaps in an effort to improve access to medtech in Latin America. OPENINGGLOBAL MARKETS I N T E R N A T I O N A L AdvaMed Executive Vice President, Global Strategy and Analysis, Ralph Ives (at left) meets with Colombian President Juan Manuel Santos in Bogota as part of an October delegation of business leaders pursuing reform and investment opportunities in Latin America. INNOVATION AGENDA PILLAR 4 Improving access to international markets by insisting on free and fair trade in medical technology, and working with foreign governments to achieve innovation-friendly regulatory and payment policies. Jon Huntsman, Jr., former U.S. ambassador to China and Singapore, former U.S. trade ambassador and two-term governor of Utah (at right) attends the AdvaMed CEO Summit with AdvaMed International Board Committee Chairman Kevin Lobo, chairman and CEO of Stryker (at left). A D V A M E D 2 0 1 5 A N N U A L R E P O R T